Filtros de búsqueda

Lista de obras de

'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning

artículo científico publicado en 2003

A classic presentation of an uncommon leukemia ⬇️

artículo científico publicado el 17 de septiembre de 2012

A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs

artículo científico

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

artículo científico publicado en 2005

A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.

artículo científico publicado en 2008

A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

artículo científico publicado en 2009

A predictive model for the detection of tumor lysis syndrome during AML induction therapy

artículo científico publicado en 2006

Abstract CT105: Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin expressing cancers

artículo científico publicado en 2015

Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia

artículo científico publicado en 2019

Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition

artículo científico publicado en 2014

Acute myelogenous leukemia: advances and limitations of treatment

artículo científico publicado en 2002

Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation

artículo científico publicado en 1995

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation

artículo científico publicado en 1996

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

artículo científico publicado en 2003

Advances in CAR T Therapy for Hematologic Malignancies

artículo científico publicado en 2020

Advances in CAR T-cell therapy for chronic lymphocytic leukemia

artículo científico publicado en 2018

Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial

artículo científico publicado en 2019

Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies ⬇️

artículo científico publicado el 1 de enero de 2011

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

artículo científico publicado en 2001

Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas ⬇️

artículo científico publicado el 24 de octubre de 2011

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia

artículo científico publicado en 2012

Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies

artículo científico publicado en 2010

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

artículo científico publicado en 2014

Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients ⬇️

artículo científico publicado el 14 de marzo de 2011

Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas

artículo científico publicado en 2016

Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy

artículo científico publicado en 1999

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease ⬇️

artículo científico publicado el 12 de julio de 2012

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

artículo científico publicado en 2018

CAR T cell viability release testing and clinical outcomes: is there a lower limit?

scientific article published on 01 November 2019

CAR T-cells merge into the fast lane of cancer care

artículo científico publicado en 2015

CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road

artículo científico publicado en 2013

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

artículo científico publicado en 2015

CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration

artículo científico publicado en 2020

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

artículo científico publicado en 2015

Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2009

Cellular immune therapy for refractory cancers: novel therapeutic strategies

artículo científico publicado en 2005

Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia

artículo científico publicado en 2017

Cellular therapy following allogeneic stem-cell transplantation ⬇️

artículo científico publicado el 1 de diciembre de 2011

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

scientific article published on 14 April 2020

Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse

artículo científico publicado en 2016

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

artículo científico publicado en 2017

Chimeric Antigen Receptor Therapy for B-cell Malignancies ⬇️

artículo científico publicado el 1 de enero de 2011

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

article by Michael M Boyiadzis et al published 4 December 2018 in Journal for Immunotherapy of Cancer

Chimeric antigen receptor T cell therapy: 25years in the making

artículo científico publicado en 2015

Chimeric antigen receptor T cells for sustained remissions in leukemia

artículo científico publicado en 2014

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

artículo científico publicado en 2015

Chimeric antigen receptor therapy for cancer

artículo científico publicado en 2014

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

artículo científico publicado en 2013

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

artículo científico publicado en 2011

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy

artículo científico publicado en 2019

Circulating osteogenic precursor cells in heterotopic bone formation

artículo científico publicado en 2009

Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

artículo científico publicado en 2016

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

artículo científico publicado en 2017

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

artículo científico publicado en 2014

Commentary (Wakoff/Porter): The Biology and Treatment of Chronic Myelogenous Leukemia

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel.

artículo científico publicado en 2018

Current concepts in the diagnosis and management of cytokine release syndrome

artículo científico publicado en 2014

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer ⬇️

artículo científico publicado el 1 de diciembre de 1997

Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

artículo científico publicado en 2016

Cytokine release syndrome and neurotoxicity following CAR T therapy for hematologic malignancies

artículo científico publicado en 2020

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights

artículo científico publicado en 2017

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

artículo científico publicado en 2016

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

artículo científico publicado en 2018

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most

artículo científico publicado en 2018

Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children

artículo científico publicado en 2020

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

artículo científico publicado en 2018

Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications?

artículo científico publicado en 2004

Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation

artículo científico publicado en 2006

Donor leukocyte infusions for multiple myeloma

artículo científico publicado en 2000

Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation

artículo científico publicado en 2007

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

artículo científico publicado en 1997

Donor leukocyte infusions in acute lymphocytic leukemia

scientific article published on 01 September 2000

Donor leukocyte infusions in myeloid malignancies: new strategies

artículo científico publicado en 2006

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant

artículo científico publicado en 1994

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

artículo científico publicado en 2016

Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning

artículo científico publicado en 2014

Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas

artículo científico publicado en 2018

Engineered T cells for cancer therapy.

artículo científico publicado en 2014

Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report

artículo científico publicado en 2017

Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy

artículo científico publicado en 2016

Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene

artículo científico publicado en 2007

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells

artículo científico publicado en 2015

Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial

scientific article published on 10 October 2018

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation

artículo científico publicado en 2009

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

artículo científico publicado en 2005

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

scientific article published on 01 July 2002

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

artículo científico publicado en 2018

Graft-versus-host disease after donor leukocyte infusions: presentation and management

artículo científico publicado en 2008

Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion

artículo científico publicado en 2006

Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction

artículo científico publicado en 2020

Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.

artículo científico publicado en 1997

Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies

scientific article published on 01 April 1999

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

artículo científico publicado en 2015

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

artículo científico publicado en 2015

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

artículo científico publicado en 2002

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT ⬇️

artículo científico publicado el 6 de febrero de 2012

Higher Donor Apheresis Blood Volumes are Associated with a Reduction in Relapse Risk and Improved Survival in Reduced Intensity Allogeneic Transplants with Unrelated Donors.

artículo científico publicado en 2018

Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation

artículo científico publicado en 2015

Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation

artículo científico publicado en 2003

Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin level

artículo científico publicado en 2008

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

artículo científico publicado en 2016

Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia

artículo científico publicado en 2015

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

artículo científico publicado en 2016

Immunotherapy with cells

artículo científico publicado en 2020

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

artículo científico publicado en 2019

Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2006

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

artículo científico publicado en 2011

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

artículo científico publicado en 2014

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

scientific article published on 01 January 1994

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.

artículo científico publicado en 2010

Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment

artículo científico publicado en 2016

Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia ⬇️

artículo científico publicado el 1 de febrero de 1998

Innovation and Access at the Mercy of Payment Policy: The Future of Chimeric Antigen Receptor Therapies

scientific article published on 01 November 2019

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation

artículo científico publicado en 2005

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

artículo científico publicado en 2015

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2010

Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.

artículo científico publicado en 2015

Leukemic gingival infiltrate as an indicator of chemotherapeutic failure following monoclonal antibody therapy: a case report

artículo científico publicado en 2003

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia

artículo científico publicado en 2020

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

scientific article published on 01 December 2005

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

artículo científico publicado en 1999

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes

artículo científico publicado en 2014

Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review

artículo científico publicado en 2004

Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature

scientific article published on 15 May 2019

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

artículo científico publicado en 2016

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

artículo científico publicado en 2017

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

artículo científico publicado en 2010

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee

artículo científico publicado en 2011

Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma

artículo científico publicado en 2015

Non-gingival soft tissue growths after allogeneic marrow transplantation

scientific article published on 01 June 1996

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

artículo científico publicado en 2002

Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma

artículo científico publicado en 2018

Novel treatments for chronic lymphocytic leukemia and moving forward

artículo científico publicado en 2014

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

scientific article published on 09 December 2019

Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients

scientific article published on 01 May 2019

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

artículo científico publicado en 2016

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

artículo científico publicado en 2015

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors ⬇️

artículo científico publicado el 18 de octubre de 2012

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

scientific article published on 10 May 2016

Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis

artículo científico publicado en 2017

Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.

artículo científico publicado en 2000

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation ⬇️

artículo científico publicado el 28 de abril de 2013

Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells

artículo científico publicado en 2017

Post-transplant lymphoproliferative disorder: a review

artículo científico publicado en 2003

Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support

artículo científico publicado en 2007

Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance ⬇️

artículo científico publicado el 14 de noviembre de 2011

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells

artículo científico publicado en 2014

Prevention and treatment of relapse after stem cell transplantation by cellular therapies

artículo científico publicado en 2018

Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies

artículo científico publicado en 2018

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transpl

scientific article published on 07 September 2013

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

scientific article published on 12 June 2006

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

artículo científico publicado en 2002

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan

artículo científico publicado en 2017

R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma

artículo científico publicado en 2014

Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens ⬇️

artículo científico publicado el 5 de junio de 2013

Reduced-Intensity Hematopoietic Stem Cell Transplants for Malignancies: Harnessing the Graft-Versus-Tumor Effect ⬇️

artículo científico publicado el 29 de octubre de 2012

Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia

artículo científico publicado en 2015

Reduced-intensity conditioned allogeneic SCT in adults with AML.

artículo científico publicado en 2015

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

artículo científico publicado en 2007

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

artículo científico publicado en 2001

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★ ⬇️

artículo científico publicado el 10 de enero de 2011

Relapse after allogeneic hematopoietic cell therapy.

artículo científico publicado en 2009

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

artículo científico publicado en 2005

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

scientific article published on 03 April 2020

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

scientific article published on 01 September 1999

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma

artículo científico publicado en 2008

Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder

artículo científico publicado en 2005

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma

scientific article published on 01 December 2020

Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation

artículo científico publicado en 2000

Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications

scientific article published on 01 October 2017

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen

artículo científico publicado en 2010

Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination

scientific article published on 01 December 1999

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

artículo científico publicado en 2011

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

artículo científico publicado en 2011

T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!

artículo científico publicado en 2005

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

artículo científico publicado en 2014

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

artículo científico publicado en 2015

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

artículo científico publicado en 2016

The cytological features of CAR(T) cells

artículo científico publicado en 2016

The graft-versus-leukemia effects of allogeneic cell therapy

artículo científico publicado en 1999

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia

artículo científico publicado en 2016

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease

scientific article published on 01 March 2019

Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.

artículo científico publicado en 2016

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

artículo científico publicado en 2018

Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease

scientific article published on 01 March 2018

Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm

artículo científico publicado en 2015

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells.

artículo científico publicado en 2015

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality

artículo científico publicado en 2008

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

artículo científico publicado en 2008

Umbilical cord blood transplantation: where do we stand?

artículo científico publicado en 2002

Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation

artículo científico publicado en 2007

Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation

artículo científico publicado en 2002

Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation

artículo científico publicado en 2016

Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients

artículo científico publicado en 2002

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

artículo científico publicado en 2003

Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation

artículo científico publicado en 2020

Voriconazole-induced periostitis after allogeneic stem cell transplantation

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda